MC Van Aalderen, MC Trappenburg… - … of Thrombosis and …, 2011 - Wiley Online Library Patients with cancer are at increased risk of thrombosis [4,5]. This may involve MPs [6,7], possibly via increased MP numbers and/or altered MP origin and functional properties in malignant disease. In a proof of concept study we addressed the changes in MP phenotypical and ... Cited by 1 - Related articles - All 2 versions
SM Kornblau, T Covey, S Putta, A Cohen… - Blood Cancer …, 2011 - nature.com ... The two longitudinally paired samples were first compared for expression of conventional surface markers used to define myeloblast maturity as shown in Figure 2a. ... (b) Cell surface markers did not identify resistance-associated myeloblast subpopulations. ... Related articles - All 2 versions
Y Ma, B Chen, X Xu, G Lin, Y Ji… - Chinese Journal of …, 2011 - Springer ...Myeloblast percentage was 5.5% (normal range: 0%-2%). A cytogenetic analysis revealed normal karyotype. ... Hemoglobin and WBC count were 96 g/L and 1.65×109/L, respectively. Bone marrow myeloblast percentage was 24%. ...
[HTML] from hindawi.comP Gaetano - Mathematical Problems in Engineering, 2011 - hindawi.com ... The malignant cell in AML usually appears at the myeloblast level. During a normal hematopoiesis activity, the myeloblast is the immature precursor of myeloid white blood cells; a normal myeloblast usually gradually evolves into a mature white blood cell. ... Related articles - Cached - All 2 versions
[PDF] from hindawi.comC Cattani… - Mathematical Problems in …, 2011 - downloads.hindawi.com ... The malignant cell in AML usually appears at the myeloblast level. During a normal hematopoiesis activity, the myeloblast is the immature precursor of myeloid white blood cells; a normal myeloblast usually gradually evolves into a mature white blood cell. ... Cited by 3 - Related articles - View as HTML
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
